Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
After Trump attended the Bitcoin conference, related concept coins generally fell, with FIGHT dropping 31.3% in 24 hours

After Trump attended the Bitcoin conference, related concept coins generally fell, with FIGHT dropping 31.3% in 24 hours

Bitget2024/07/28 10:03

PANews reported on July 28th, according to CoinGecko data, after Trump attended the Bitcoin conference, several related concept coins fell broadly. Among them:

-TRUMP dropped by 19.9% in 24 hours and is now priced at $5.82;

-MAGA Hat dropped by 23.3% in 24 hours and is now priced at $0.0001096;

-STRUMP dropped by 25% in 24 hours and is now priced at $0.008859;

-TREMP dropped by 24.6% in 24 hours and is now priced at $0.4028;

-Super Trump dropped by 25% in the last day and its current price is $0.008859;

-FIGHT decreased by a whopping of31.3% within the past day with its current price being $0.01061.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment

According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.

智通财经•2026/11/06 08:27

GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions

Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.

智通财经•2026/11/06 07:56